US0554771032
US0554771032
Bicara Therapeutics Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 155.604.000 | 82.389.000 | 88.9% | |
| Operating Income | -155.604.000 | -82.389.000 | 88.9% |
| Pretax Income | -137.733.000 | -67.808.000 | 103.1% |
| Net Income Common Stockholders | -137.950.000 | -67.995.000 | 102.9% |
| -- | -- | -- | |
| -- | -- | -- |